Skip to main content
Log in

Poly(D,L-Lactide) Nanocapsules Containing Non-Steroidal Anti-Inflammatory Drugs: Gastrointestinal Tolerance Following Intravenous and Oral Administration

  • Note
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCES

  1. P. A. Todd and E. M. Sorkin. Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. Drugs, 35: 244–285 (1988).

    Google Scholar 

  2. A. J. Collins and L. J. Notorianni. The acute action of fenbufen and piroxicam on the gastric mucosa as measured by gastric microbleeding. J. Int. Med. Res., 12: 179–183 (1984).

    Google Scholar 

  3. J. W. Fara and E. Myrback. Formulation and dosage form design in drug-induced topical irritation of the gastrointestinal tract. Pharm. Res., 7: 616–620 (1990).

    Google Scholar 

  4. E. C. Soehngen, E. Godin-Ostro, F. G. Fielder, R. S. Ginsberg, M. A. Slusher and A. L. Weiner. Encapsulation of indomethacin in liposomes provides protection against both gastric and intestinal ulceration when orally administered to rats. Arthritis and Rheumatism, 31: 412–421 (1989).

    Google Scholar 

  5. N. Ammoury, M. Dubrasquet, H. Fessi, J-P. Devissaguet, F. Puisieux and S. Benita. Indomethacin-loaded poly(D,L-lactide) nanocapsules: protection from gastrointestinal ulceration and antiinflammatory activity evaluation on rats. Clin. Mater., 13: 121–130 (1993).

    Google Scholar 

  6. S. S. Guterres, H. Fessi, G. Barratt, J-P. Devissaguet and F. Puisieux. Poly (D,L-lactide) nanocapsules containing diclofenac: I. Formulation and stability study. Int. J. Pharm., 113: 57–63 (1995).

    Google Scholar 

  7. S. Bolton. Pharmaceutical Statistic—Practical and Clinical Applications. Marcel Dekker, New York (1984).

    Google Scholar 

  8. D. A. Brodie, P. G. Cook, J. Bauer and G. E Dagle. Indomethacin-induced intestinal lesions in the rats. Toxicol. Appl. Pharmacol., 17: 615–624 (1970).

    Google Scholar 

  9. K. J. Levy, D. B. Paone and W. J. Krause. Acute effect of systemic aspirin on gastric mucosa in man. Digestive Diseases and Sciences, 25: 97–99 (1980).

    Google Scholar 

  10. D. E. Duggan, K. F. Hooke, R. M. Noll and K. C. Kwan. Enterohepatic circulation of indomethacin and its role in intestinal irritation. Biochem. Pharmacol., 25: 1749–1754 (1975).

    Google Scholar 

  11. F. Fawaz, F. Bonini, M. Guyot, A. M. Lagueny, H. Fessi and J-P. Devissaguet. Influence of poly(D,L-lactide) nanocapsules on the biliary clearance and enterohepatic circulation of indomethacin in the rabbit. Pharm. Res., 10: 750–756 (1993).

    Google Scholar 

  12. V. Cioli, S. Putzolu, V. Rossi, P. Scorza-Barcellona and C. Corradino. The role of direct tissue contact in the production of gastrointestinal ulcers by anti-inflammatory drugs in rats. Toxicol. Appl. Pharmacol., 50: 283–289 (1979).

    Google Scholar 

  13. N. Ammoury, H. Fessi, J. P. Devissaguet, M. Dubrasquet and S. Benita. Jejunal absorption, pharmacological activity and pharmacokinetic evaluation of indomethacin loaded poly(D,L-lactide) and poly(isobutyl-cyanoacrylate) nanocapsules in rats. Pharm. Res., 8: 101–105 (1991).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guterres, S.S., Fessi, H., Barratt, G. et al. Poly(D,L-Lactide) Nanocapsules Containing Non-Steroidal Anti-Inflammatory Drugs: Gastrointestinal Tolerance Following Intravenous and Oral Administration. Pharm Res 12, 1545–1547 (1995). https://doi.org/10.1023/A:1016208125979

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016208125979

Navigation